Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome

Prader-Willi syndrome (PWS) is a complex, multi-system, neurodevelopmental disorder characterised by neonatal muscular hypotonia, short stature, high risk of obesity, hypogonadism, intellectual disabilities, distinct behavioural/psychiatric problems and abnormal body composition with increased body...

Descripción completa

Detalles Bibliográficos
Autores principales: Höybye, Charlotte, Holland, Anthony J., Driscoll, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869190/
https://www.ncbi.nlm.nih.gov/pubmed/33557878
http://dx.doi.org/10.1186/s13023-020-01651-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869190/
https://www.ncbi.nlm.nih.gov/pubmed/33557878
http://dx.doi.org/10.1186/s13023-020-01651-x

Ejemplares similares